National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement Amendment Instrument 2011 (No. 2) (No. PB 17 of 2011) (Cth)

Case

PB 17 of 2011

National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement Amendment Instrument 2011 (No. 2)

National Health Act 1953

___________________________________________________________________________

I, FELICITY MCNEILL, Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsections 100(1) and (2) of the National Health Act 1953.

Dated 24 February 2011

FELICITY MCNEILL

Acting First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health and Ageing

___________________________________________________________________

1              Name of Instrument

(1)This Instrument is the National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement Amendment Instrument 2011 (No.2).

(2)This Instrument may also be cited as PB 17 of 2011.

2                Commencement

    This Instrument commences on 1 March 2011.

3              Amendments to PB 117 of 2010

            Schedule 1 amends PB 117 of 2010.

Schedule 1                   Amendments

  1. Schedule 1, entry for “BCG Immunotherapeutic” (Baccillis Calmette- Guérin/ Connaught strain)

omit from the column headed ‘Form’:

Single dose set comprising 1 vial powder for intravesical administration containing 6.6 to 19.2 x 10 8 CFU and 1 vial diluent 3 mL

substitute:

Powder for intravesical administration containing 6.6 to 19.2 x 10 8 CFU

  1. Schedule 1, entry for Bleomycin  

omit:

Blenoxane BQ EMP C1139
C1198 		10 0

  1. Schedule 1, after entry for Docetaxel in the form Solution concentrate for I.V. infusion 20 mg in 1 mL:

insert in the columns in the order indicated:

Solution concentrate for I.V. infusion 20 mg in 2 mL Injection DBL Docetaxel Concentrated Injection HH EMP C1194 C1742 C2416 C2439 C2732 C3051 C3292 C3428 P3051 1 0
Docetaxel Ebewe IT EMP C1194 C1742 C2416 C2439 C2732 C3051 C3292 C3428 P3051 1 0
DBL Docetaxel Concentrated Injection HH EMP C1194 C1742 C2416 C2439 C2732 C3051 C3292 C3428 P1194 P1742 P2416 P2439 P2732 P3292 P3428 2 0
Docetaxel Ebewe IT EMP C1194 C1742 C2416 C2439 C2732 C3051 C3292 C3428 P1194 P1742 P2416 P2439 P2732 P3292 P3428 2 0

  1. Schedule 1, after entry for Docetaxel in the form Solution concentrate for I.V. infusion 80 mg in 4 mL:

Insert in the columns in the order indicated:

Solution concentrate for I.V. infusion 80 mg in 8 mL Injection DBL Docetaxel Concentrated Injection HH EMP C1194 C1742 C2416 C2439 C2732 C3051 C3292 C3428 1 0
Docetaxel Ebewe IT EMP C1194 C1742 C2416 C2439 C2732 C3051 C3292 C3428 1 0

  1. Schedule 1, entry for Ondansetron

substitute:

Ondansetron Tablet (orally disintegrating) 4 mg Oral Ondansetron ODT-DRLA RZ EMP C3050 4 0
Tablet (orally disintegrating) 8 mg Oral Ondansetron ODT-DRLA RZ EMP C3050 4 0
Tablet 4 mg (as hydrochloride dihydrate) Oral APO-Ondansetron TX EMP C3050 4 0
Ondansetron-DRLA RZ EMP C3050 4 0
Ondaz SZ EMP C3050 4 0
Onsetron 4 ZP EMP C3050 4 0
Zofran GK EMP C3050 4 0
Tablet 8 mg (as hydrochloride dihydrate) Oral APO-Ondansetron TX EMP C3050 4 0
Ondansetron-DRLA RZ EMP C3050 4 0
Ondaz SZ EMP C3050 4 0
Onsetron 8 ZP EMP C3050 4 0
Zofran GK EMP C3050 4 0
Wafer 4 mg Oral Ondaz Zydis SZ EMP C3050 4 0
Zofran Zydis GK EMP C3050 4 0
Wafer 8 mg Oral Ondaz Zydis SZ EMP C3050 4 0
Zofran Zydis GK EMP C3050 4 0
Syrup 4 mg (as hydrochloride dihydrate) per 5 mL, 50 mL Oral Zofran syrup 50 mL GK EMP C3050 1 0
I.V. injection 4 mg (as hydrochloride dihydrate) in 2 mL Injection Ondansetron-Claris AE EMP C3050 1 0
Ondaz SZ EMP C3050 1 0
Onsetron ZP EMP C3050 1 0
Pfizer Australia Pty Ltd PF EMP C3050 1 0
Zofran GK EMP C3050 1 0
I.V. injection 8 mg (as hydrochloride dihydrate) in 4 mL Injection Ondansetron-Claris AE EMP C3050 1 0
Ondaz SZ EMP C3050 1 0
Onsetron ZP EMP C3050 1 0
Pfizer Australia Pty Ltd PF EMP C3050 1 0
Zofran GK EMP C3050 1 0

Note

All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.

See

Actions
Download as PDF Download as Word Document
Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0